Mikami S - Search Results

1

Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure.

Matsui I, Hamano T, Mikami S, Fujii N, Takabatake Y, Nagasawa Y, Kawada N, Ito T, Rakugi H, Imai E, Isaka Y. Matsui I, et al. Among authors: mikami s. Kidney Int. 2009 May;75(9):915-28. doi: 10.1038/ki.2008.700. Epub 2009 Feb 4. Kidney Int. 2009. PMID: 19190677 Free article.

2

Fetuin-mineral complex reflects extraosseous calcification stress in CKD.

Hamano T, Matsui I, Mikami S, Tomida K, Fujii N, Imai E, Rakugi H, Isaka Y. Hamano T, et al. Among authors: mikami s. J Am Soc Nephrol. 2010 Nov;21(11):1998-2007. doi: 10.1681/ASN.2009090944. Epub 2010 Oct 14. J Am Soc Nephrol. 2010. PMID: 20947626 Free PMC article.

3

[Low dose estrogen replacement therapy (ERT) for postmenopausal hemodialysis (HD) patients].

Hamano T, Fujii N, Ito T, Imai E, Mikami S, Katayama M, Obi Y. Hamano T, et al. Among authors: mikami s. Clin Calcium. 2005 Sep;15 Suppl 1:161-6; discussion 166. Clin Calcium. 2005. PMID: 16279020 Clinical Trial. Japanese.

4

Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD).

Fujii N, Hamano T, Mikami S, Nagasawa Y, Isaka Y, Moriyama T, Horio M, Imai E, Hori M, Ito T. Fujii N, et al. Among authors: mikami s. Nephrol Dial Transplant. 2007 Jun;22(6):1601-7. doi: 10.1093/ndt/gfl567. Epub 2006 Nov 23. Nephrol Dial Transplant. 2007. PMID: 17124283 Clinical Trial.

5

Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients.

Mikami S, Hamano T, Fujii N, Nagasawa Y, Isaka Y, Moriyama T, Matsuhisa M, Ito T, Imai E, Hori M. Mikami S, et al. Hypertens Res. 2008 Jun;31(6):1163-70. doi: 10.1291/hypres.31.1163. Hypertens Res. 2008. PMID: 18716364

6

Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.

Tomida K, Hamano T, Mikami S, Fujii N, Okada N, Matsui I, Nagasawa Y, Moriyama T, Ito T, Imai E, Isaka Y, Rakugi H. Tomida K, et al. Among authors: mikami s. Bone. 2009 Apr;44(4):678-83. doi: 10.1016/j.bone.2008.11.016. Epub 2008 Dec 9. Bone. 2009. PMID: 19111635

7

Usefulness of bone resorption markers in hemodialysis patients.

Hamano T, Tomida K, Mikami S, Matsui I, Fujii N, Imai E, Rakugi H, Isaka Y. Hamano T, et al. Among authors: mikami s. Bone. 2009 Jul;45 Suppl 1:S19-25. doi: 10.1016/j.bone.2009.03.663. Epub 2009 Mar 28. Bone. 2009. PMID: 19332165

8

The impact of diabetes mellitus on vitamin D metabolism in predialysis patients.

Tanaka H, Hamano T, Fujii N, Tomida K, Matsui I, Mikami S, Nagasawa Y, Ito T, Moriyama T, Horio M, Imai E, Isaka Y, Rakugi H. Tanaka H, et al. Among authors: mikami s. Bone. 2009 Nov;45(5):949-55. doi: 10.1016/j.bone.2009.07.016. Epub 2009 Jul 23. Bone. 2009. PMID: 19631779

9

Guideline-practice gap in the management of predialysis chronic kidney disease mineral bone disorder in Japan.

Hamano T, Fujii N, Matsui I, Nakano C, Inoue K, Tomida K, Mikami S, Okada N, Tsubakihara Y, Rakugi H, Isaka Y. Hamano T, et al. Among authors: mikami s. Ther Apher Dial. 2011 Jun;15 Suppl 1:2-8. doi: 10.1111/j.1744-9987.2011.00918.x. Ther Apher Dial. 2011. PMID: 21595844

10

Combined use of vitamin D status and FGF23 for risk stratification of renal outcome.

Nakano C, Hamano T, Fujii N, Matsui I, Tomida K, Mikami S, Inoue K, Obi Y, Okada N, Tsubakihara Y, Isaka Y, Rakugi H. Nakano C, et al. Among authors: mikami s. Clin J Am Soc Nephrol. 2012 May;7(5):810-9. doi: 10.2215/CJN.08680811. Epub 2012 Feb 23. Clin J Am Soc Nephrol. 2012. PMID: 22362065 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

663 results

Search Page

Filters